Press Releases
India’s growing biopharma market: monoclonal antibodies R&D and production Designing sterile connection systems
Monoclonal antibodies (MAbs) have been extraordinary tools in the field of bioscience due to their high level of specificity and selective binding ability. ...
Press Releases
OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD
Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an...
Press Releases
Axol Bioscience Launches Human iPSC-derived Microglia
Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible...
Press Releases
Genoscience Pharma named EuropaBio’s Most Innovative European Biotech SME for 2018
Genoscience Pharma, a clinical-stage biotechnology company dedicated to discovering and developing anticancer drugs, is delighted to announce that it received the Most Innovative European Biotech...
Press Releases
New Digital Marketplace for Life Science Products – Built with Scientists in Mind
Labviva, an AI-powered digital marketplace for life science reagents, instrumentation and services announces its launch to create scientifically informed purchasing decisions. "We...
Press Releases
AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed...
Press Releases
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.